[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE60025494D1 - Epothilon zusammensetzungen - Google Patents

Epothilon zusammensetzungen

Info

Publication number
DE60025494D1
DE60025494D1 DE60025494T DE60025494T DE60025494D1 DE 60025494 D1 DE60025494 D1 DE 60025494D1 DE 60025494 T DE60025494 T DE 60025494T DE 60025494 T DE60025494 T DE 60025494T DE 60025494 D1 DE60025494 D1 DE 60025494D1
Authority
DE
Germany
Prior art keywords
epothilone
compositions
liposomal compositions
provides liposomal
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025494T
Other languages
English (en)
Other versions
DE60025494T2 (de
Inventor
Jean-Claude Sonntag
Markus Wartmann
Karl-Heinz Altmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10858600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60025494(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE60025494D1 publication Critical patent/DE60025494D1/de
Application granted granted Critical
Publication of DE60025494T2 publication Critical patent/DE60025494T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60025494T 1999-08-04 2000-08-02 Epothilon zusammensetzungen Expired - Lifetime DE60025494T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9918429 1999-08-04
GBGB9918429.3A GB9918429D0 (en) 1999-08-04 1999-08-04 Organic compounds
PCT/EP2000/007488 WO2001010412A1 (en) 1999-08-04 2000-08-02 Epothilone compositions

Publications (2)

Publication Number Publication Date
DE60025494D1 true DE60025494D1 (de) 2006-04-06
DE60025494T2 DE60025494T2 (de) 2006-07-27

Family

ID=10858600

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025494T Expired - Lifetime DE60025494T2 (de) 1999-08-04 2000-08-02 Epothilon zusammensetzungen

Country Status (8)

Country Link
EP (1) EP1198225B1 (de)
AT (1) ATE315380T1 (de)
AU (1) AU6279500A (de)
DE (1) DE60025494T2 (de)
DK (1) DK1198225T3 (de)
ES (1) ES2254203T3 (de)
GB (1) GB9918429D0 (de)
WO (1) WO2001010412A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999001124A1 (en) 1996-12-03 1999-01-14 Sloan-Kettering Institute For Cancer Research Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6589968B2 (en) 2001-02-13 2003-07-08 Kosan Biosciences, Inc. Epothilone compounds and methods for making and using the same
US6893859B2 (en) 2001-02-13 2005-05-17 Kosan Biosciences, Inc. Epothilone derivatives and methods for making and using the same
CA2471509A1 (en) * 2002-01-14 2003-07-17 Novartis Ag Combinations comprising epothilones and anti-metabolites
DK1503756T3 (da) * 2002-05-01 2009-11-16 Novartis Ag Epothilonderivat til behandling af hepatom og andre cancersygdomme
DK1530465T4 (en) 2002-06-26 2016-03-21 Medigene Ag A method of producing a cationic liposomal preparation comprising a lipophilic compound.
CN100553634C (zh) * 2002-10-11 2009-10-28 达纳-法伯癌症研究公司 用于治疗多发性骨髓瘤的埃坡霉素衍生物
EP2135868A1 (de) 2002-11-07 2009-12-23 Kosan Biosciences Incorporated Trans 9,10-dehydroepothilon c und d, deren derivate und verfahren zu ihren herstellung
US7691838B2 (en) 2003-05-30 2010-04-06 Kosan Biosciences Incorporated Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
US7691392B2 (en) 2005-04-29 2010-04-06 Kosan Biosciences Incorporated Method of treating multiple myeloma using 17-AAG or 17-AG or a prodrug of either
RU2011142620A (ru) * 2009-03-25 2013-04-27 Новартис Аг ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЛЕКАРСТВЕННОЕ СРЕДСТВО И киРНК
WO2011146638A1 (en) 2010-05-18 2011-11-24 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6515016B2 (en) * 1996-12-02 2003-02-04 Angiotech Pharmaceuticals, Inc. Composition and methods of paclitaxel for treating psoriasis

Also Published As

Publication number Publication date
ATE315380T1 (de) 2006-02-15
EP1198225A1 (de) 2002-04-24
AU6279500A (en) 2001-03-05
DE60025494T2 (de) 2006-07-27
ES2254203T3 (es) 2006-06-16
DK1198225T3 (da) 2006-03-27
EP1198225B1 (de) 2006-01-11
WO2001010412A1 (en) 2001-02-15
GB9918429D0 (en) 1999-10-06

Similar Documents

Publication Publication Date Title
NL301200I2 (nl) Voclosporine
EA199900373A2 (ru) Фармацевтические композиции
DE60139185D1 (de) Vernetzbare perfluoroelastomarzusammensetzung
IT1308628B1 (it) Composizioni fluoroelastomeriche.
AU2001239725A1 (en) Antibacterial agents
CY2003002I1 (el) Συνθεσεις ζιπρασιδονης
FI20010780A0 (fi) Parannetut koostumukset
TR199802240T2 (de)
DE60022980D1 (de) Umgerührte Reibschweissverbindungen enthaltendes Bauelement
PT1473036E (pt) Solvato de hemitartarato de zolpidem
NO20023244D0 (no) Hydrogeler
DE60025494D1 (de) Epothilon zusammensetzungen
SV2003000981A (es) Fenil-heterociclil-eteres ref. pcs10973
DZ2815A1 (fr) Inhibiteurs de protéase.
DK1233913T3 (da) Plastfolie
BR0103435B1 (pt) composiÇço de tonalizador.
IT1311356B1 (it) Disposizione di macchine.
IT1318819B1 (it) Amplificatore di corrente
ITTO20020745A1 (it) Composizione.
CY1110139T1 (el) Γλυκοπεπτιδικα αντιβιοτικα
CY1115144T1 (el) Παραγωγα του uk-2a
HN2000000084A (es) Inhibidores de metaloproteasa.
ES1048844Y (es) Cupon precinto desprendible de cajas de medicamentos.
IT1304174B1 (it) Composizioni perossidiche
FI981420A (fi) Jatkopistokytkin

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN